A 5-gene panel was identified (NKX6-2, CA10, DBC1, MYO3A, and PENK or SOX11) and the panel had an 85% sensitivity and a 95% specificity for the detection of bladder cancer. This evidence concerns the gene MYO3A and urinary bladder cancer.